- Home
- SIDU vs PLUR Comparison
SIDU vs PLUR Comparison
Compare SIDU & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIDU
- PLUR
- Stock Information
- Founded
- SIDU 2012
- PLUR 2001
- Country
- SIDU United States
- PLUR Israel
- Employees
- SIDU N/A
- PLUR N/A
- Industry
- SIDU Telecommunications Equipment
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SIDU Telecommunications
- PLUR Health Care
- Exchange
- SIDU Nasdaq
- PLUR Nasdaq
- Market Cap
- SIDU 37.7M
- PLUR 36.9M
- IPO Year
- SIDU 2021
- PLUR N/A
- Fundamental
- Price
- SIDU $0.75
- PLUR $3.95
- Analyst Decision
- SIDU
- PLUR Strong Buy
- Analyst Count
- SIDU 0
- PLUR 1
- Target Price
- SIDU N/A
- PLUR $12.00
- AVG Volume (30 Days)
- SIDU 1.3M
- PLUR 52.2K
- Earning Date
- SIDU 11-14-2025
- PLUR 11-12-2025
- Dividend Yield
- SIDU N/A
- PLUR N/A
- EPS Growth
- SIDU N/A
- PLUR N/A
- EPS
- SIDU N/A
- PLUR N/A
- Revenue
- SIDU $3,623,538.00
- PLUR $1,326,000.00
- Revenue This Year
- SIDU N/A
- PLUR $97.38
- Revenue Next Year
- SIDU $100.00
- PLUR $293.97
- P/E Ratio
- SIDU N/A
- PLUR N/A
- Revenue Growth
- SIDU N/A
- PLUR 121.74
- 52 Week Low
- SIDU $0.70
- PLUR $3.22
- 52 Week High
- SIDU $7.65
- PLUR $7.13
- Technical
- Relative Strength Index (RSI)
- SIDU 34.35
- PLUR 48.02
- Support Level
- SIDU $0.70
- PLUR $3.50
- Resistance Level
- SIDU $0.86
- PLUR $4.12
- Average True Range (ATR)
- SIDU 0.08
- PLUR 0.37
- MACD
- SIDU -0.02
- PLUR 0.03
- Stochastic Oscillator
- SIDU 13.59
- PLUR 36.83
About SIDU Sidus Space Inc.
Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.